DE69703878T2 - Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen - Google Patents

Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen

Info

Publication number
DE69703878T2
DE69703878T2 DE69703878T DE69703878T DE69703878T2 DE 69703878 T2 DE69703878 T2 DE 69703878T2 DE 69703878 T DE69703878 T DE 69703878T DE 69703878 T DE69703878 T DE 69703878T DE 69703878 T2 DE69703878 T2 DE 69703878T2
Authority
DE
Germany
Prior art keywords
pharmaceutical preparations
guanidinium compounds
guanidinium
compounds
nnr4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69703878T
Other languages
English (en)
Other versions
DE69703878D1 (de
Inventor
Jean-Marie Lehn
Pierre Lehn
Jean-Pierre Vigneron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232562&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69703878(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9602604A external-priority patent/FR2745569B1/fr
Priority claimed from FR9609557A external-priority patent/FR2751972B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE69703878D1 publication Critical patent/DE69703878D1/de
Application granted granted Critical
Publication of DE69703878T2 publication Critical patent/DE69703878T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69703878T 1996-03-01 1997-02-28 Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen Expired - Lifetime DE69703878T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9602604A FR2745569B1 (fr) 1996-03-01 1996-03-01 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications
FR9609557A FR2751972B1 (fr) 1996-07-30 1996-07-30 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications
PCT/FR1997/000364 WO1997031935A1 (fr) 1996-03-01 1997-02-28 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications

Publications (2)

Publication Number Publication Date
DE69703878D1 DE69703878D1 (de) 2001-02-15
DE69703878T2 true DE69703878T2 (de) 2001-04-26

Family

ID=26232562

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69703878T Expired - Lifetime DE69703878T2 (de) 1996-03-01 1997-02-28 Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen

Country Status (18)

Country Link
US (2) US6143729A (de)
EP (1) EP0888379B1 (de)
JP (1) JP4271260B2 (de)
KR (1) KR19990087372A (de)
AT (1) ATE198599T1 (de)
AU (1) AU723998B2 (de)
BR (1) BRPI9707889B8 (de)
CZ (1) CZ295225B6 (de)
DE (1) DE69703878T2 (de)
DK (1) DK0888379T3 (de)
ES (1) ES2154453T3 (de)
GR (1) GR3035205T3 (de)
HU (1) HU228072B1 (de)
IL (1) IL125926A (de)
NO (1) NO311806B1 (de)
PT (1) PT888379E (de)
SK (1) SK283575B6 (de)
WO (1) WO1997031935A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884430B1 (en) * 1997-02-10 2005-04-26 Aventis Pharma S.A. Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
FR2763943B1 (fr) * 1997-05-28 1999-07-09 Rhone Poulenc Rorer Sa Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
FR2777017B1 (fr) * 1998-04-02 2002-08-23 Rhone Poulenc Rorer Sa Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications
BR9909350A (pt) * 1998-04-02 2000-12-12 Aventis Pharma Sa Compostos, composição, utilização de um composto, e, processos para preparação dos compostos, para transferência de ácido nucleicos para as células e para tratamento de doenças por meio de administração de um ácido nucleico
DE10109898A1 (de) 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
FR2824557B1 (fr) * 2001-05-14 2003-08-29 Aventis Pharma Sa Derives lipidiques de polythiouree
WO2002092558A1 (fr) * 2001-05-14 2002-11-21 Gencell S.A. Derives lipidiques de polythiouree
FR2829136B1 (fr) * 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
SI1479985T1 (sl) 2002-01-17 2017-10-30 Alfa Laval Corporate Ab Potopni uparjalnik, ki vsebuje ploščni toplotni izmenjevalnik in cilindrično ohišje, kjer je nameščen ploščni toplotni izmenjevalnik
JP4980893B2 (ja) * 2005-04-28 2012-07-18 日本曹達株式会社 新規なグアニジン化合物、製造方法及びそれらを含有する殺菌性組成物
EP2069500B1 (de) * 2006-10-04 2014-09-24 Centre National De La Recherche Scientifique (Cnrs) Zusammensetzungen mit einer sirna und lipidischen 4,5-disubstituierten 2-desoxystreptaminring-aminoglykosid-derivaten und verwendungen davon
JP2012509258A (ja) * 2008-11-17 2012-04-19 エンゾン ファーマシューティカルズ，インコーポレーテッド 核酸送達系のための分岐カチオン性脂質

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
CA2176715A1 (en) * 1993-11-24 1995-06-01 Timothy D. Heath Amphiphilic derivatives of guanidine
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5811406A (en) * 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes

Also Published As

Publication number Publication date
IL125926A (en) 2004-09-27
DE69703878D1 (de) 2001-02-15
HUP9902465A1 (hu) 1999-12-28
US6143729A (en) 2000-11-07
JP2000506136A (ja) 2000-05-23
BR9707889B1 (pt) 2010-03-23
HU228072B1 (en) 2012-09-28
CZ295225B6 (cs) 2005-06-15
DK0888379T3 (da) 2001-01-29
IL125926A0 (en) 1999-04-11
AU723998B2 (en) 2000-09-07
ATE198599T1 (de) 2001-01-15
NO983691D0 (no) 1998-08-12
ES2154453T3 (es) 2001-04-01
JP4271260B2 (ja) 2009-06-03
EP0888379A1 (de) 1999-01-07
KR100452062B1 (de) 2005-04-08
SK283575B6 (sk) 2003-09-11
BR9707889A (pt) 2000-01-04
NO311806B1 (no) 2002-01-28
CZ277298A3 (cs) 1998-12-16
WO1997031935A1 (fr) 1997-09-04
US6316422B1 (en) 2001-11-13
KR19990087372A (ko) 1999-12-27
EP0888379B1 (de) 2001-01-10
SK118298A3 (en) 1999-02-11
GR3035205T3 (en) 2001-04-30
NO983691L (no) 1998-08-12
PT888379E (pt) 2001-05-31
HUP9902465A3 (en) 2009-10-28
AU1930497A (en) 1997-09-16
BRPI9707889B8 (pt) 2016-11-08

Similar Documents

Publication Publication Date Title
DE69416119D1 (de) Harnstoff- und amidderivate und ihre verwendung zur kontrolle von zellmembranständigen kalium-kanälen
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
SE9301911D0 (sv) New peptide derivatives
BR0210078A (pt) Composto, uso do mesmo, e, formulação farmacêutica
DE60043349D1 (de) Chinazolin-derivate und ihre verwendung als arzneimittel
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
BR9711134A (pt) Composto e uso de um composto
DE69703878D1 (de) Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
DK0696270T3 (da) 4-Aminofluorbenzamider og deres anvendelse som cytotoksiske promedikamenter
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
AU1070895A (en) Indole-derived arylpiperazines as ligands for 5HT1-like receptors 5HT1B and 5HT1D
TR200001010T2 (tr) Ürokinaz önleyicileri olan izokinolinler.
DK0437563T3 (da) Bioligiske aktive lægemiddelpolymerderivater
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
CY1106396T1 (el) Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν
ATE89549T1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
ATE94168T1 (de) Peptide.
TWI263639B (en) Novel tetrazole derivative
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.
DK0777471T3 (da) Inhibering af leukotrienbiosynese med urinstofderivater
ATE95169T1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC